Specialised staff required for the nutrition and family teams in supportive care
Cancer is distressing for patients and families, and supportive care is today an important part of therapy
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Cancer is distressing for patients and families, and supportive care is today an important part of therapy
Gastric cancer (GC) is one of the most aggressive oncologic diseases, with a 5 year median survival of 25%. Surgery remains the only curative option, although with a high recurrence rate.
Novel approaches and drugs are showing promising results in solid cancers.
A small study presented at ECC2015 shows positive responses in patients with Merkel cell carcinoma after few weeks of treatment with checkpoint inhibitors
The genomic landscape of lung cancer is becoming clearer as new mutations are identified in different types of cancers. Two studies presented at the European Cancer Congress (ECC) 2015 in Vienna report new insights into this expanding area.
Loss of fertility is a primary concern for some breast cancer patients as 10% of breast cancers occur in women younger than 40 years of age. Chemotherapy destroys rapidly dividing cells and the ovaries can be sensitive to this.
Preliminary safety results from the PERUSE study presented at the European Cancer Congress 2015 (ECC 2015) in Vienna, Austria, open the door for the taxanes nab-paclitaxel and paclitaxel to be used in HER2-positive patients with metastatic breast cancer
Atezolizumab is set to substantially change treatment strategies for patients with refractory lung cancer, according to Dr Martin Reck, Chief Oncology Physician in the Department of Thoracic Oncology, Hospital Grosshansdorf, Germany. Reck’s comments came as the results from the POPLAR and BIRCH studies showing the first results of efficacy with atezolizumab across lines were presented at the European Cancer Congress 2015 (ECC 2015) in Vienna, Austria.
Access to quality cancer care is still a big issue in Europe, and there is great heterogeneity in the availability of drugs, screening programmes and resources among countries. Neglected cancer populations exist with lower rates of early diagnosis and treatment compliance
The international community of high-standard palliative programmes is growing as the prestigious title is accredited to 18 new cancer centres
ESMO Open is dedicated to publishing high-quality medical research and educational content from all disciplines of oncology, with a focus on innovative clinical and translational cancer research. The first articles will be published in January 2016.
New award will will acknowledge someone who has actively worked to sensitise organisations to perceive the female oncology workforce as a valuable resource
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.